Understanding Autoimmune Mechanisms in Multiple Sclerosis
Author Information
Author(s): A. ACHIRON, M. GUREVICH, D. MAGALASHVILI, I. KISHNER, M. DOLEVA, M. MANDEL
Primary Institution: Sheba Medical Center and Sackler School of Medicine, Tel-Aviv University
Hypothesis
The study investigates the effect of immunomodulatory treatment on gene expression in multiple sclerosis patients and the role of cytokine-related pathways in disease pathogenesis.
Conclusion
Cytokine-associated genes are involved in various pathogenic pathways in multiple sclerosis and are related to immunomodulatory treatment effects.
Supporting Evidence
- A signature of 535 genes distinguished treatment effects between treated and untreated MS patients.
- 30 genes related to cytokine-associated pathways were identified when comparing MS patients to healthy controls.
- Seven cytokine-associated genes were found within the immunomodulatory treatment signature.
Takeaway
This study looks at how certain genes behave in people with multiple sclerosis and how treatments can change those behaviors.
Methodology
Gene expression microarrays were used to analyze peripheral blood mononuclear cells from MS patients to identify gene expression patterns associated with treatment effects.
Potential Biases
null
Limitations
The study included patients on various immunomodulatory treatments for different durations, which limited the ability to define specific drug effects.
Participant Demographics
Twenty-six patients with definite MS and a relapsing-remitting disease course, including 13 treated and 13 untreated patients.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website